Research from UW Medicine and collaborators indicates that a drug-like molecule can activate innate immunity and induce genes to control infection in a range of RNA viruses, including West Nile, dengue, hepatitis C, influenza A, respiratory syncytial, Nipah, Lassa and Ebola.
The findings, published today in the Journal of Virology, show promising evidence for creating a broad-spectrum antiviral.
Compound found to trigger innate immunity against viruses
206.685.8289
206.685.8377